MannKind and Thirona Bio, Inc. join forces to evaluate potential inhaled therapy for fibrotic lung diseases MannKind will conduct formulation and preclinical studies of a [...] Amy Conrad2023-10-25T09:59:29-07:00June 10, 2021|